ipid changes after induction therapy in patients with Inflammatory Bowel Disease: effect of different drug classes and inflammatio
Completed
- Conditions
- Inflammatory bowel disease
- Registration Number
- NL-OMON22770
- Lead Sponsor
- Erasmus Medical Center (investigator-initiated)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
ii) IBD diagnosis, ii) age =>17 years, iii) starting systemic registered IBD drug therapy
Exclusion Criteria
i) the use of lipid lowering drugs (with the exception of cholestyramine on stable dose throughout the study), ii) supplements containing plant sterols/stanols or cholestin, iii) pregnancy, iv) a history of liver transplantation
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method ipid changes after induction therapy (total cholesterol, HDL-c, LDL-c, triglycerides, apolipoprotein-B and lipoprotein a)
- Secondary Outcome Measures
Name Time Method Association with drug class and inflammation